News
Watch
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Episodes

Specialty:

All

Year:

All

EP. 1: Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

January 16th 2017

EP. 2: Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

January 16th 2017

EP. 3: Monitoring Azole Levels in Transplant Patients

January 16th 2017

EP. 4: Morbidity from CMV Infection in Transplant Patients

January 16th 2017

EP. 5: The Need for CMV Prophylaxis in the Transplant Setting

January 16th 2017

EP. 6: Letermovir for CMV Prophylaxis in Transplant Patients

January 16th 2017

EP. 7: Letermovir Phase III Trial

January 16th 2017

Trending on OncLive

FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC

FDA Accepts NDA for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer

Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer

Dr Galsky on Systemic Therapy Advances in Muscle-Invasive Bladder Cancer

Dr Cooper on Biomarker Selection for DLL3-Targeted Therapies in ES-SCLC